Back to News
May 7, 2026 4:00 PM

Roche To Acquire PathAI In Up To $1.05 Billion Deal To Expand Digital Pathology Push

Roche (OTC:RHHBY) said Wednesday it will acquire U.S.-based digital pathology and AI company PathAI in a deal worth up to $1.05 billion, including milestone payments.

The acquisition will expand Roche's digital pathology and AI diagnostics capabilities. PathAI is set to join its diagnostics division once the deal closes later this year.

Read Also:

C4 Therapeutics Deepens Roche Alliance To Target Breakthrough Cancer Therapies

Deal Builds On Existing Partnership

Under the agreement, Roche will pay $750 million upfront, with additional ...